; and (ii) at least once a month to the extent that the administration of such psychotropic drug to such resident is in accordance with the plan of care that the resident has in place. (D) Compliance Effective beginning on the date that is one year and 180 days after the date of the enactment of this paragraph, a skilled nursing facility shall comply with the standardized protocol developed under subparagraph (A). (E) No preemption Nothing in this paragraph shall preempt any provision of State or Federal law that provides broader rights with respect to written informed consent for residents of facilities. . (2) Nursing facilities Section 1919(b) of the Social Security Act ( 42 U.S.C. 1396r(b) ) is amended by adding at the end the following new paragraph: (9) Standardized protocol for obtaining informed consent from a resident prior to prescribing psychotropic drugs for a use not approved by the Food and Drug Administration (A) Protocol Not later than the date that is one year after the date of the enactment of this paragraph, the Secretary, taking into account the results of the study conducted by the Comptroller General of the United States under section 8(a)(3) of the Quality Care for Nursing Home Residents Act of 2019 and in consultation with stakeholder groups (including residents of skilled nursing facilities, family members of such residents, advocates for such residents, long-term care ombudsmen, and providers), shall develop a standardized protocol for nursing facilities to obtain written informed consent, in accordance with this paragraph, from a resident (or, if applicable, the resident’s designated health care agent or other surrogate under State law or regulation) prior to prescribing a psychotropic drug to the resident for a use not approved by the Food and Drug Administration. (B) Requirements The standardized protocol developed under subparagraph (A) shall include the following: (i) A requirement, with respect to a resident, that— (I) the facility, with the involvement of the prescriber, inform the